Literature DB >> 9879040

Outcomes of preventative care in a diabetic foot specialty clinic.

D G Armstrong1, L B Harkless.   

Abstract

The purpose of the study was to report the incidence of ulceration, reulceration, and amputation in 341 patients treated in a multidisciplinary clinic over the course of 3 years. Patients enrolled were 57.8% male, with a mean age of 53.2 +/- 11.8 years. All were assessed using the University of Texas Diabetic Foot Classification System. Of these patients, 118 fell into category 0 (protective sensation intact), 98 into category 1 (loss of protective sensation, LOPS), 77 into category 2 (LOPS with deformity), and 48 into category 3 (LOPS, deformity, previous history of ulcer or amputation). Outcomes assessed included any incident ulcerations or amputations. The authors stratified patients based on their compliance to follow up appointments. Non compliance was defined as missing > 50% of scheduled appointments in any calendar year. Thirty of the above subjects were classified as noncompliant. Prior to analysis, the authors initially stratified subjects into compliant and noncompliant groups. If further stratified by foot category, the incidence of ulceration in the compliant group was 0 for diabetic foot categories 0 and 1, 3.5/1,000/year for category 2, and 18/1,000/year for category 3. One category 3 patient required a partial first-ray amputation. The yearly incidence of amputation for the entire cohort was therefore 1.1/1,000/year. For categories 0-2 the incidence was 0, and for category 3, it was 9/1,000/year. Patients stratified into the noncompliant group were approximately 54 times more likely to ulcerate than patients who returned regularly for their scheduled care (81.8% ulcer prevalence vs. 5.4%, p < .0001, OR = 54.0, Cl = 7.5-1,425.0). Additionally, noncompliant category 3 patients were over 20 times more likely to receive an amputation than their compliant counterparts (45.5% amputation prevalence vs. 2.7%, p < .002, OR = 2.5-819.0). The study concluded that multidisciplinary diabetes care team, which includes aggressive foot care and consistent treatment-based risk classification, may be effective in profoundly mitigating the occurrence and recurrence of diabetic foot sequelae, including ulceration and amputation. Furthermore, patient noncompliance to routine preventative care appears to be associated with a significantly higher prevalence of ulceration and amputation.

Entities:  

Mesh:

Year:  1998        PMID: 9879040     DOI: 10.1016/s1067-2516(98)80022-7

Source DB:  PubMed          Journal:  J Foot Ankle Surg        ISSN: 1067-2516            Impact factor:   1.286


  8 in total

1.  Temperature monitoring to assess, predict, and prevent diabetic foot complications.

Authors:  Lawrence A Lavery; David G Armstrong
Journal:  Curr Diab Rep       Date:  2007-12       Impact factor: 4.810

2.  Five-year outcomes of patients attending a diabetic foot clinic in a tertiary referral centre.

Authors:  Hannah Forde; Sarah Wrigley; Liam Tomas O'Murchadha; Lyn Cusack; Sinead Casserly; Daragh Moneley; James Walsh; Diarmuid Smith
Journal:  Ir J Med Sci       Date:  2019-10-24       Impact factor: 1.568

Review 3.  Diagnosing diabetic foot osteomyelitis: narrative review and a suggested 2-step score-based diagnostic pathway for clinicians.

Authors:  Anurag Markanday
Journal:  Open Forum Infect Dis       Date:  2014-08-07       Impact factor: 3.835

4.  Reduction of pain via platelet-rich plasma in split-thickness skin graft donor sites: a series of matched pairs.

Authors:  John D Miller; Timothy M Rankin; Natalie T Hua; Tina Ontiveros; Nicholas A Giovinco; Joseph L Mills; David G Armstrong
Journal:  Diabet Foot Ankle       Date:  2015-01-22

5.  Non-invasive assessment of vibration perception and protective sensation in people with diabetes mellitus: inter- and intra-rater reliability.

Authors:  Sean Michael Lanting; Martin Jeremy Spink; Peta Ellen Tehan; Stephanie Vickers; Sarah Louise Casey; Vivienne Helaine Chuter
Journal:  J Foot Ankle Res       Date:  2020-01-16       Impact factor: 2.303

6.  Prevention of lower-limb lesions and reduction of morbidity in diabetic patients.

Authors:  Antônio Homem do Amaral Júnior; Leonã Aparecido Homem do Amaral; Marcus Gomes Bastos; Luciana Campissi do Nascimento; Marcio José Martins Alves; Marco Antonio Percope de Andrade
Journal:  Rev Bras Ortop       Date:  2014-07-04

7.  Serum procollagen type 1 N propeptide: A novel diagnostic test for diabetic foot osteomyelitis - A case-control study.

Authors:  Oliver G Hayes; Venkat N Vangaveti; Usman H Malabu
Journal:  J Res Med Sci       Date:  2018-05-30       Impact factor: 1.852

Review 8.  Reliability of recommended non-invasive chairside screening tests for diabetes-related peripheral neuropathy: a systematic review with meta-analyses.

Authors:  Ally McIllhatton; Sean Lanting; David Lambkin; Lucy Leigh; Sarah Casey; Vivienne Chuter
Journal:  BMJ Open Diabetes Res Care       Date:  2021-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.